Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets.

Abstract excerpt

Hemophilia is classified into mild, moderate, and severe based on coagulation factor activity levels. Factor replacement and prophylaxis regimens in persons with hemophilia have helped to reduce bleeding and its related complications. With several newer treatments, some already approved and others soon to be, there may be a need to consider health-related quality of life in addition to bleed prevention as the...

Topics

Join the communities discussing this publication.

• Factor VIII
• Hemophilia A
• Hemophilia B
• Hemorrhage
• Phenotype